Abstract:Background Lack of appropriate tools and techniques to study fate and functional integration of newly generated neurons has so far hindered understanding of neurogenesis' relevance under physiological and pathological conditions. Current analyses are either dependent on mitotic labeling, for example BrdU-incorporation or retroviral infection, or on the detection of transient immature neuronal markers. Here, we report a transgenic mouse model (DCX-CreERT2) for time-resolved fate analysis of newly generated neurons. This model is based on the expression of a tamoxifen-inducible Cre recombinase under the control of a doublecortin (DCX) promoter, which is specific for immature neuronal cells in the CNS. Results In the DCX-CreERT2 transgenic mice, expression of CreERT2 was restricted to DCX+ cells. In the CNS of transgenic embryos and adult DCX-CreERT2 mice, tamoxifen administration caused the transient translocation of CreERT2 to the nucleus, allowing for the recombination of loxP-flanked sequences. In our system, tamoxifen administration at E14.5 resulted in reporter gene activation throughout the developing CNS of transgenic embryos. In the adult CNS, neurogenic regions were the primary sites of tamoxifen-induced reporter gene activation. In addition, reporter expression could also be detected outside of neurogenic regions in cells physiologically expressing DCX (e.g. piriform cortex, corpus callosum, hypothalamus). Four weeks after recombination, the vast majority of reporter-expressing cells were found to co-express NeuN, revealing the neuronal fate of DCX+ cells upon maturation. Conclusions This first validation demonstrates that our new DCX-CreERT2 transgenic mouse model constitutes a powerful tool to investigate neurogenesis, migration and their long-term fate of neuronal precursors. Moreover, it allows for a targeted activation or deletion of specific genes in neuronal precursors and will thereby contribute to unravel the molecular mechanisms controlling neurogenesis.

Functional ProTracer identifies patterns of cell proliferation in tissues and underlying regulatory mechanisms

Genetic recording of in vivo cell proliferation by ProTracer

A Powerful Transgenic Tool for Fate Mapping and Functional Analysis of Newly Generated Neurons

Functional characterization of Lmo2-Cre transgenic zebrafish.

Dual Cre and Dre recombinases mediate synchronized lineage tracing and cell subset ablation in vivo

Triple-cell lineage tracing by a dual reporter on a single allele

Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation

Cell‐Lineage Tracing in Zebrafish Embryos with an Expanded Genetic Code

Cre Reconstitution Allows for Dna Recombination Selectively in Dual-Marker-Expressing Cells in Transgenic Mice

Genetic lineage tracing of resident stem cells by DeaLT

Tracking proliferative history in lymphocyte development with cre-mediated sister chromatid recombination.

Establishment Of A Transgenic Pig Fetal Fibroblast Reporter Cell Line For Monitoring Cre Recombinase Activity

A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targeting

Simultaneous quantitative assessment of two distinct cell lineages with a nuclear-localized dual genetic reporter

Efficient photoactivatable Dre recombinase for cell type-specific spatiotemporal control of genome engineering in the mouse

Construction of Afp-cre-lacZ Transgenic Mouse Model

Genetic lineage tracing with multiple DNA recombinases: A user's guide for conducting more precise cell fate mapping studies

Production of a Reporter Transgenic Pig for Monitoring Cre Recombinase Activity.

The robust, high-throughput, and temporally regulated roxCre and loxCre reporting systems for genetic modifications

Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines

A P53-Based Genetic Tracing System to Follow Postnatal Cardiomyocyte Expansion in Heart Regeneration.